Your browser doesn't support javascript.
loading
Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?
Fortney, John C; Ratzliff, Anna D; Blanchard, Brittany E; Johnson, Morgan; Ferro, Lori; Austin, Elizabeth J; Williams, Emily C; Duncan, Mark H; Merrill, Joseph O; Thomas, Jennifer; Kitay, Brandon; Schoenbaum, Michael; Heagerty, Patrick J; Saxon, Andrew J.
Afiliação
  • Fortney JC; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington; Advancing Integrated Mental Health Solutions (AIMS) Center, University of Washington; and Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Pu
  • Ratzliff AD; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, and Advancing Integrated Mental Health Solutions (AIMS) Center, University of Washington, Seattle, Washington.
  • Blanchard BE; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington.
  • Johnson M; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington.
  • Ferro L; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington.
  • Austin EJ; Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, Washington.
  • Williams EC; Department of Health Systems and Population Health, School of Public Health, University of Washington, and Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle, Washington.
  • Duncan MH; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington.
  • Merrill JO; Department of Medicine, School of Medicine, University of Washington, Seattle, Washington.
  • Thomas J; Morris Hospital and Healthcare Centers, Morris, Illinois.
  • Kitay B; Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia.
  • Schoenbaum M; National Institute of Mental Health, Bethesda, Maryland.
  • Heagerty PJ; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington.
  • Saxon AJ; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, and Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound, Seattle, Washington.
Ann Intern Med ; 176(10): 1431-1433, 2023 10.
Article em En | MEDLINE | ID: mdl-37844317
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2023 Tipo de documento: Article